RxDoctor Payments Data

Sara Cathcart, DPM

Foot & Ankle Surgery · Warwick, RINPI 1649622598

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,559 of the $3,374 with a category attached, or 75.8%. 20 manufacturers reported payments, led by Kairos Surgical Inc at 24.8% of the total. Reporting peaked in 2019 at $1,825 and has fallen 88.7% since, to $207 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in RI, where the typical reported total is $3,840.

$3,374in general payments, 2019–2025

Across 54 payments — averaging $62.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$835
  • Smith+Nephew$706
  • Stryker$294
  • Medtronic$263
  • Bioventus LLC$234
  • Mallinckrodt Enterprises LLC$191
  • plus $850 from 14 others

What the payments were for

  • Food & beverage$2,55976%
  • Education$81524%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,374 in reported general payments places this provider in the 45th percentile of 58 foot & ankle surgery providers in Rhode Island.

See all foot & ankle surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$71,178
Medicare patients
400
Services billed
1,539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox12$529
Ammonium Lactate16$362
Meloxicam28$157

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Warwick

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →